Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 8979 | 37.555 |
09:34 ET | 533 | 37.525 |
09:36 ET | 940 | 37.61 |
09:38 ET | 900 | 37.32 |
09:39 ET | 778 | 37.3 |
09:41 ET | 700 | 37.235 |
09:43 ET | 1801 | 37.26 |
09:45 ET | 3385 | 37.465 |
09:48 ET | 16945 | 37.52 |
09:50 ET | 4709 | 37.295 |
09:52 ET | 1886 | 37.4 |
09:54 ET | 1473 | 37.34 |
09:56 ET | 1317 | 37.2411 |
09:57 ET | 1761 | 37.345 |
09:59 ET | 4347 | 37.325 |
10:01 ET | 33584 | 37.3 |
10:03 ET | 3400 | 37.19 |
10:06 ET | 1570 | 37.22 |
10:08 ET | 2200 | 37.16 |
10:10 ET | 1326 | 37.17 |
10:12 ET | 3111 | 37.05 |
10:14 ET | 2524 | 37.1 |
10:15 ET | 1000 | 37.055 |
10:17 ET | 18803 | 36.71 |
10:19 ET | 10836 | 36.785 |
10:21 ET | 14695 | 36.84 |
10:24 ET | 8502 | 36.905 |
10:26 ET | 2561 | 36.9175 |
10:28 ET | 6570 | 36.94 |
10:30 ET | 3183 | 36.97 |
10:32 ET | 5256 | 36.98 |
10:33 ET | 14197 | 36.88 |
10:35 ET | 9016 | 36.86 |
10:37 ET | 3800 | 36.82 |
10:39 ET | 800 | 36.8 |
10:42 ET | 3300 | 36.86 |
10:44 ET | 907 | 36.81 |
10:46 ET | 2185 | 36.8 |
10:48 ET | 5132 | 36.855 |
10:50 ET | 100 | 36.855 |
10:51 ET | 800 | 36.845 |
10:53 ET | 3459 | 36.977 |
10:55 ET | 3234 | 37.02 |
10:57 ET | 4606 | 36.915 |
11:00 ET | 4486 | 36.94 |
11:02 ET | 4923 | 36.98 |
11:04 ET | 899 | 36.97 |
11:06 ET | 688 | 36.96 |
11:08 ET | 22426 | 36.86 |
11:09 ET | 3465 | 36.85 |
11:11 ET | 4450 | 36.845 |
11:13 ET | 14099 | 36.8 |
11:15 ET | 1308 | 36.835 |
11:18 ET | 3412 | 36.86 |
11:20 ET | 559 | 36.85 |
11:22 ET | 2535 | 36.8 |
11:24 ET | 1790 | 36.815 |
11:26 ET | 956 | 36.77 |
11:27 ET | 574 | 36.8 |
11:29 ET | 500 | 36.79 |
11:31 ET | 2957 | 36.81 |
11:33 ET | 345 | 36.81 |
11:36 ET | 1765 | 36.82 |
11:38 ET | 1203 | 36.84 |
11:40 ET | 2579 | 36.86 |
11:42 ET | 4193 | 36.85 |
11:44 ET | 1779 | 36.78 |
11:45 ET | 9242 | 36.66 |
11:47 ET | 1100 | 36.65 |
11:49 ET | 6196 | 36.71 |
11:51 ET | 2932 | 36.72 |
11:54 ET | 4724 | 36.735 |
11:56 ET | 1328 | 36.73 |
11:58 ET | 4610 | 36.71 |
12:00 ET | 1657 | 36.705 |
12:02 ET | 1431 | 36.76 |
12:03 ET | 3067 | 36.735 |
12:05 ET | 500 | 36.72 |
12:07 ET | 1200 | 36.727 |
12:09 ET | 1219 | 36.69 |
12:12 ET | 755 | 36.72 |
12:14 ET | 1168 | 36.715 |
12:16 ET | 440 | 36.725 |
12:18 ET | 600 | 36.715 |
12:20 ET | 2345 | 36.7442 |
12:21 ET | 400 | 36.735 |
12:23 ET | 1119 | 36.67 |
12:25 ET | 4949 | 36.67 |
12:27 ET | 100 | 36.66 |
12:30 ET | 1100 | 36.62 |
12:32 ET | 200 | 36.61 |
12:34 ET | 729 | 36.635 |
12:36 ET | 2935 | 36.665 |
12:38 ET | 130 | 36.6501 |
12:39 ET | 702 | 36.68 |
12:41 ET | 800 | 36.675 |
12:43 ET | 4173 | 36.645 |
12:45 ET | 858 | 36.62 |
12:48 ET | 100 | 36.62 |
12:50 ET | 700 | 36.63 |
12:52 ET | 2959 | 36.64 |
12:54 ET | 1100 | 36.66 |
12:56 ET | 100 | 36.67 |
12:57 ET | 1600 | 36.635 |
12:59 ET | 700 | 36.63 |
01:01 ET | 1532 | 36.625 |
01:03 ET | 1489 | 36.625 |
01:06 ET | 1995 | 36.625 |
01:08 ET | 2306 | 36.64 |
01:10 ET | 2982 | 36.66 |
01:12 ET | 1500 | 36.64 |
01:14 ET | 11143 | 36.71 |
01:15 ET | 3289 | 36.77 |
01:17 ET | 1869 | 36.77 |
01:19 ET | 1200 | 36.79 |
01:21 ET | 2948 | 36.76 |
01:24 ET | 3376 | 36.79 |
01:26 ET | 1100 | 36.805 |
01:28 ET | 400 | 36.8 |
01:30 ET | 200 | 36.81 |
01:32 ET | 600 | 36.78 |
01:33 ET | 906 | 36.75 |
01:35 ET | 500 | 36.72 |
01:37 ET | 1423 | 36.71 |
01:39 ET | 2234 | 36.67 |
01:42 ET | 1826 | 36.655 |
01:44 ET | 4564 | 36.64 |
01:46 ET | 2425 | 36.66 |
01:48 ET | 700 | 36.6478 |
01:50 ET | 200 | 36.645 |
01:51 ET | 2443 | 36.66 |
01:53 ET | 1300 | 36.635 |
01:55 ET | 7066 | 36.63 |
01:57 ET | 505 | 36.63 |
02:00 ET | 802 | 36.64 |
02:02 ET | 1861 | 36.619 |
02:04 ET | 2140 | 36.59 |
02:06 ET | 1463 | 36.61 |
02:08 ET | 8073 | 36.7 |
02:09 ET | 2100 | 36.735 |
02:11 ET | 2354 | 36.675 |
02:13 ET | 1127 | 36.63 |
02:15 ET | 1800 | 36.615 |
02:18 ET | 2524 | 36.64 |
02:20 ET | 1850 | 36.595 |
02:22 ET | 4009 | 36.57 |
02:24 ET | 2936 | 36.565 |
02:26 ET | 2932 | 36.62 |
02:27 ET | 2045 | 36.605 |
02:29 ET | 708 | 36.64 |
02:31 ET | 1317 | 36.62 |
02:33 ET | 2918 | 36.61 |
02:36 ET | 704 | 36.6 |
02:38 ET | 500 | 36.61 |
02:40 ET | 1083 | 36.6 |
02:42 ET | 2800 | 36.615 |
02:44 ET | 1095 | 36.625 |
02:45 ET | 3067 | 36.665 |
02:47 ET | 6097 | 36.66 |
02:49 ET | 3624 | 36.64 |
02:51 ET | 600 | 36.64 |
02:54 ET | 600 | 36.64 |
02:56 ET | 4293 | 36.65 |
02:58 ET | 1931 | 36.63 |
03:00 ET | 1204 | 36.65 |
03:02 ET | 6703 | 36.65 |
03:03 ET | 200 | 36.655 |
03:05 ET | 618 | 36.655 |
03:07 ET | 1367 | 36.67 |
03:09 ET | 5489 | 36.71 |
03:12 ET | 617 | 36.72 |
03:14 ET | 2151 | 36.75 |
03:16 ET | 300 | 36.745 |
03:18 ET | 985 | 36.745 |
03:20 ET | 3723 | 36.78 |
03:21 ET | 11852 | 36.865 |
03:23 ET | 5446 | 36.845 |
03:25 ET | 1834 | 36.91 |
03:27 ET | 2113 | 37.02 |
03:30 ET | 4679 | 36.93 |
03:32 ET | 8604 | 36.872 |
03:34 ET | 3777 | 36.85 |
03:36 ET | 1645 | 36.825 |
03:38 ET | 1440 | 36.82 |
03:39 ET | 2990 | 36.85 |
03:41 ET | 3362 | 36.86 |
03:43 ET | 3437 | 36.84 |
03:45 ET | 2804 | 36.845 |
03:48 ET | 4091 | 36.94 |
03:50 ET | 9161 | 37.001 |
03:52 ET | 10446 | 37.115 |
03:54 ET | 12129 | 37.13 |
03:56 ET | 17747 | 37.225 |
03:57 ET | 22527 | 37.23 |
03:59 ET | 47909 | 37.31 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 5.4B | -14.0x | --- |
Halozyme Therapeutics Inc | 5.7B | 18.5x | --- |
Apellis Pharmaceuticals Inc | 5.0B | -11.9x | --- |
CRISPR Therapeutics AG | 4.8B | -20.8x | --- |
ACADIA Pharmaceuticals Inc | 2.4B | -1,149.2x | --- |
Intra-Cellular Therapies Inc | 6.9B | -56.4x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.4B |
---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.34 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -14.0x |
Price/Sales (TTM) | 7.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -45.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.